Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 18Lymphoma, Large B-Cell, Diffuse 12Lymphoma, Non-Hodgkin 9Lymphoma, B-Cell, Marginal Zone 4Leukemia 4Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Hodgkin Disease 3Waldenstrom Macroglobulinemia 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Nausea 2Leukemia, Lymphocytic, Chronic, B-Cell 2Vomiting 1Orbital lymphoma 1Myelodysplastic Syndromes 1Myasthenia Gravis 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1Immunoblastic Lymphadenopathy 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1

Interventions

ibritumomab tiuxetan 1Rituximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Orbital lymphoma × Rituximab × Clear all
NCT00387023 2013-11-18

Radioimmunotherapy With 90Y Zevalin for Orbital Lymphoma

M.D. Anderson Cancer Center

Phase NA Completed
12 enrolled 3 charts
Lymphoid

Orbital lymphoma, Lymphoma, Lymphoma, Non-Hodgkin

Data powered by HemOnc (CC BY 4.0) Colophon âš¡